A Randomized, Double-blind, Parallel, Placebo-controlled Study for the Assessment of the Safety and Efficacy of BTL-TML-HSV for the Treatment of Recurrent Symptomatic Oral Herpes Virus Infection

Trial Profile

A Randomized, Double-blind, Parallel, Placebo-controlled Study for the Assessment of the Safety and Efficacy of BTL-TML-HSV for the Treatment of Recurrent Symptomatic Oral Herpes Virus Infection

Completed
Phase of Trial: Phase I/II

Latest Information Update: 21 Jul 2015

At a glance

  • Drugs BTL-TML001 (Primary)
  • Indications Herpetic stomatitis
  • Focus Therapeutic Use
  • Sponsors Beech Tree Labs
  • Most Recent Events

    • 21 Jul 2015 Pooled analysis results of this and another phase II trial (CTP 235128) were published in a Beech Tree Labs media release.
    • 02 Oct 2012 Planned End Date changed from 1 Jun 2012 to 1 Nov 2012 as reported by ClinicalTrials.gov.
    • 04 Jan 2012 Planned end date changed from 1 Feb 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top